IBI110,Sintilimab
eli lilly,Innovent Biologics
['ibi110', 'innovent']
dcbn news: innovent presents phase 1b clinical data of ibi110 (anti-lag-3 monoclonal antibody) at the 2023 asco annual meeting: rockville, md. and suzhou, china, june 4, 2023 /prnewswire/ innovent ... #biotech #news 
Life science news and jobs from Washington DC, Maryland and Virginia. Part of @BiotechNetworks, connecting #biotech since 2008.